Published in Hepatology on July 01, 1996
Risks or remedies? Safety aspects of herbal remedies in the UK. J R Soc Med (1998) 1.44
Reactive metabolites in the biotransformation of molecules containing a furan ring. Chem Res Toxicol (2012) 0.78
"Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci (2017) 0.75
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology (1999) 1.92
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther (1995) 1.78
Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology (1997) 1.61
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology (1998) 1.58
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol (1996) 1.46
Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J Hepatol (2001) 1.44
The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab (2004) 1.43
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol (1990) 1.25
Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther (2001) 1.19
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol (1997) 1.18
Polymorphism of dextromethorphan oxidation in a French population. Br J Clin Pharmacol (1987) 1.17
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf (1996) 1.16
[Hepatitis caused by diclofenac]. Gastroenterol Clin Biol (1983) 1.15
Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol (1988) 1.15
Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology (2001) 1.14
Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology (2000) 1.13
Perhexiline maleate-induced cirrhosis. Gastroenterology (1979) 1.12
Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology (1993) 1.11
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochem Pharmacol (1983) 1.11
Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther (1990) 1.10
Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology (1978) 1.10
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol (1997) 1.10
Amodiaquine-induced fulminant hepatitis. J Hepatol (1988) 1.05
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest (1990) 1.04
Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes. J Pharmacol Exp Ther (1992) 1.04
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther (1989) 1.00
Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. Gastroenterology (1975) 1.00
Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J Pharmacol Exp Ther (1994) 0.99
Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology (1995) 0.99
Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation. Am J Physiol (1997) 0.99
Effect of surgery under general anaesthesia on antipyrine clearance. Br J Clin Pharmacol (1978) 0.98
Phenylpropanoid glycosides from Lantana camara and Lippia multiflora. Planta Med (1997) 0.98
Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol (1997) 0.98
Cross hepatotoxicity between tricyclic antidepressants. Gut (1986) 0.97
Effect of bioactive compounds from Sainfoin ( Onobrychis viciifolia Scop.) on the in vitro larval migration of Haemonchus contortus: role of tannins and flavonol glycosides. Parasitology (2005) 0.96
Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology (1990) 0.95
Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again. Lancet (1981) 0.95
Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology (1994) 0.95
Direct characterization of isoquinoline alkaloids in a crude plant extract by ion-pair liquid chromatography-electrospray ionization tandem mass spectrometry: example of Eschscholtzia californica. J Chromatogr A (2000) 0.95
Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod (1992) 0.95
Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology (2001) 0.93
Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther (1990) 0.93
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology (1977) 0.92
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients. Br J Clin Pharmacol (1989) 0.91
Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology (1997) 0.91
Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol (2000) 0.90
Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther (1988) 0.90
Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology (2000) 0.90
Drug interactions and hepatitis produced by some macrolide antibiotics. J Antimicrob Chemother (1985) 0.90
Amazonian plants from Peru used by Quechua and Mestizo to treat malaria with evaluation of their activity. J Ethnopharmacol (2007) 0.90
Effects of macrolide antibiotics on drug metabolism in rats and in humans. Int J Clin Pharmacol Res (1983) 0.89
Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochem Pharmacol (1981) 0.88
In vitro effects of three woody plant and sainfoin extracts on 3rd-stage larvae and adult worms of three gastrointestinal nematodes. Parasitology (2004) 0.88
Peliosis hepatis induced by 6-thioguanine administration. Gut (1988) 0.88
[Hepatitis caused by cyproheptadine (Periactine). A case and review of the literature]. Gastroenterol Clin Biol (1988) 0.88
Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding. Biochem Pharmacol (1987) 0.88
Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology (1995) 0.88
Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther (1991) 0.87
Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping. Ann Intern Med (1988) 0.87
In vitro effects of four tropical plants on three life-cycle stages of the parasitic nematode, Haemonchus contortus. Res Vet Sci (2005) 0.87
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione. J Pharmacol Exp Ther (1983) 0.87
Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochem Pharmacol (1983) 0.87
Prolonged cholestasis after cyproheptadine-induced acute hepatitis. J Clin Gastroenterol (1987) 0.87
Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies. J Hepatol (1997) 0.87
Effects of four tanniferous plant extracts on the in vitro exsheathment of third-stage larvae of parasitic nematodes. Parasitology (2006) 0.86
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology (1995) 0.86
Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology (1988) 0.86
Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans. Biochem Pharmacol (1982) 0.86
Pirprofen-induced fulminant hepatitis. Gastroenterology (1985) 0.85
Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma. Cancer Invest (2007) 0.85
Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol (1994) 0.85
Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol (1999) 0.85
The kinetics of exsheathment of infective nematode larvae is disturbed in the presence of a tannin-rich plant extract (sainfoin) both in vitro and in vivo. Parasitology (2007) 0.84
Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology (1979) 0.84
In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides. Antimicrob Agents Chemother (1997) 0.84
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. Dig Dis Sci (1994) 0.84
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice. Biochem Pharmacol (1984) 0.84
Antibacterial activity of the leaves of Phyllanthus discoideus. J Ethnopharmacol (1990) 0.83
Justicidin B, a cytotoxic principle from Justicia pectoralis. J Nat Prod (1988) 0.83
Fulminant hepatitis after lisinopril administration. Gastroenterology (1990) 0.83
Furoquinoline Alkaloids from Vepris heterophylla. Planta Med (1994) 0.83
Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice. J Pharmacol Exp Ther (1986) 0.83
Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies. Mol Pharmacol (1994) 0.83
Vesicular transport of newly synthesized cytochromes P4501A to the outside of rat hepatocyte plasma membranes. J Pharmacol Exp Ther (2000) 0.83
Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid. Xenobiotica (1979) 0.82
Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Ther (2001) 0.82
Hepatotoxicity of germander in mice. Gastroenterology (1994) 0.82
Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction. Gastroenterology (1996) 0.82
Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo. Apoptosis (2002) 0.82